메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한배뇨장애요실금학회 International Neurourology Journal International Neurourology Journal 제11권 제1호
발행연도
2007.1
수록면
54 - 58 (5page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose: To evaluate the influence of prostate volume on the changes of International Prostate Symptoms Score (IPSS) and other clinical parameters in men with lower urinary tract symptoms (LUTS) undergoing tamsulosin treatment. Materials and Methods: Patients were evaluated initially by IPSS/QoL questionnaire, digital rectal examination (DRE), transrectal ultrasonography (TRUS), urinalysis, serum prostate-specific antigen (PSA), maximal urine flow rate (Qmax) and post-void residual urine (PVR). Patients were grouped according to baseline prostate volume (PV): PV<20 ml (group A), 20 ml≤PV<30 ml (group B), 30 ml≤PV<40 ml (group C), PV≥40 ml (group D). All the patients were given tamsulosin 0.2 mg per day. After 8 weeks of tamsulosin treatment, clinical efficacy was determined by changes of IPSS/QoL scores, Qmax and PVR volumes. Results: Overall 672 patients were enrolled initially and 580 patients have finished the protocol. After treatment, total IPSS score was decreased by 6.2 point (31.7%) and Qmax was increased by 1.8ml/sec (29.7%). When clinical outcomes were compared according to the different PV groups, there were no statistically significant differences among groups except significant Qmax changes between group B and D. Conclusion: Clinical efficacy of short term tamsulosin medication is not affected by the prostate volume. It may be necessary that the results of this study should be confirmed in further long term follow-ups. (J. Korean Continence Society 2007;11:54-58)

목차

등록된 정보가 없습니다.

참고문헌 (18)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0